Regulating The CGT Workflow To Improve Patient Safety: Audience Q&A

Source: Cytiva

At the conclusion of the presentation, our expert panelists, Nimi Chhina, Ph.D., J.D. Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs, Worldwide Research & Development at BioMarin Pharmaceutical Inc., and Robert G. Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma, provided detailed responses to questions from our audience. Tune in to hear their responses to questions around potential safety concerns to save time on long follow-ups on post- or pre-approvals and more.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene